|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 209/04 | (2006.01) |
| C07D 209/32 | (2006.01) | ||
| A61P 31/14 | (2006.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61K 31/4045 | (2006.01) |
| (11) | Number of the document | 3601225 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18715611.2 |
| Date of filing the European patent application | 2018-03-29 | |
| (97) | Date of publication of the European application | 2020-02-05 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-02 |
| (46) | Date of publication of the claims translation | 2021-08-10 |
| (86) | Number | PCT/EP2018/058077 |
| Date | 2018-03-29 |
| (87) | Number | WO 2018/178238 |
| Date | 2018-10-04 |
| (30) | Number | Date | Country code |
| 17164045 | 2017-03-31 | EP |
| (72) |
BARDIOT, Dorothée Alice Marie-Eve , BE
KESTELEYN, Bart Rudolf Romanie , BE
BONFANTI, Jean-Francois , FR
RABOISSON, Pierre Jean-Marie Bernard , BE
MARCHAND, Arnaud Didier M , BE
|
| (73) |
Janssen Pharmaceuticals, Inc. ,
1125 Trenton-Harbourton Road, Titusville, NJ 08560,
US
Katholieke Universiteit Leuven , Waaistraat 6, bus 5105, 3000 Leuven, BE |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Pakeistieji indolino dariniai kaip dengės viruso replikacijos inhibitoriai |
| SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2026-02-26 | 9 | 208.00 EUR |
| 2027-03-29 |